AI case study

Novo NordiskClinical trial research

Silos forced teams to manually chase data. Now, AI agents identify adverse events in seconds, eliminating weeks of cross-referencing.

Published|2 months ago

Key results

Projected New Value
$157M+
Projected Efficiency
$14M+

Result highlights

Unlock 3 result highlights

The story

Context

A century-old global pharmaceutical leader focused on diabetes and chronic diseases, managing billions of clinical trial data points across highly regulated environments.

Challenge

A "patchwork spiderweb" of siloed systems forced teams to manually pass information between departments, creating bottlenecks in clinical trial...

Solution
Unlock full story

Scope & timeline

  • 9 months from concept to MVP
  • 1,000 active users on data platform
  • 20% developer adoption of clinical data

Quotes

Unlock 11 more quotes

The company

Novo Nordisk logo

Novo Nordisk

novonordisk.com

Pharmaceutical company specializing in diabetes, obesity, and rare blood disorders.

IndustryPharmaceuticals & Biotech
LocationBagsværd, Denmark
Employees50K-100K
Founded1923

The vendor

Databricks is a Big Data company that offers a unified analytics platform for data science, engineering, and analytics teams.

IndustrySoftware & Platforms
LocationSan Francisco, California, United States
Employees10K-50K
Founded2013

Similar Case Studies

Related implementations across industries and use cases

58 AI case studies in Scientific Discovery

137 AI case studies in Pharmaceuticals & Biotech

1,414 AI case studies in Product Engineering